• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: BOSTON SCIENTIFIC - MAPLE GROVE ION?; CORONARY DRUG-ELUTING STENT

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

BOSTON SCIENTIFIC - MAPLE GROVE ION?; CORONARY DRUG-ELUTING STENT Back to Search Results
Model Number H7493902416300
Device Problem Occlusion Within Device (1423)
Patient Problems Chest Pain (1776); Myocardial Infarction (1969); Nausea (1970); Reocclusion (1985); Thrombosis (2100); Diaphoresis (2452)
Event Date 12/27/2012
Event Type  Injury  
Manufacturer Narrative
Device is a combination product.Device evaluated by mfr: it is indicated that the device will not be returned for evaluation.A review of the batch history, historical trending, and similar complaint trending review for the product family will be conducted.If there is any further relevant information from that review, a supplemental medwatch will be filed.(b)(4).
 
Event Description
Ion us coa clinical study.It was reported that acute myocardial infarction (ami) and restenosis occurred.In (b)(6) 2011, the patient was referred for cardiac catheterization.Subsequently, the index procedure was performed.Target lesion #1 was de novo lesion located in the 1st obtuse marginal (om) with 95% stenosis and was 12 mm long with a reference vessel diameter of 3 mm.Target lesion #1 was treated with pre-dilatation and placement of a 3.00 mm x 16 mm ion us coa stent.Following post dilatation, residual stenosis was 0%.3 days post procedure, the patient was discharged on aspirin and clopidogrel.In (b)(4) 2012, the patients cardiac enzymes were found to be elevated and an event of mi was reported by the site.Subsequently, the patient was hospitalized on the same day.The following day, electrocardiogram (ecg) suggested unknown type of mi.It was observed that the patient experienced ischemic symptoms.The 100% restenosis of the stent located in 1st om was treated with balloon angioplasty and placement of drug eluting stent with 0% residual stenosis.The event was considered resolved without residual effects.4 days later, the patient was discharged.
 
Manufacturer Narrative
(b)(4).
 
Event Description
It was further reported that at the time of event, the patient presented with left hip fracture and coronary angiography was performed.During balloon angioplasty, an unspecified luge guide wire was advanced, but was unable to cross the lesion.Finally the lesion was crossed with non-bsc guide wire with the help of 2.5 x 8 mm emerge balloon and subsequently placement of a 3.0 x 16 mm promus element stent.In addition, a correction has been made to the previously reported restenosis in the proximal first obtuse marginal (om) to stent thrombosis of the study stent.
 
Manufacturer Narrative
Describe event or problem, patient code updated.Relevant tests/lab data corrected and updated.(b)(4).
 
Event Description
It was further reported that prior index procedure patient presented with cardiac arrest which was diagnosed as myocardial infarction (mi) and was referred for cardiac catheterization.Coronary angiography was performed.In (b)(6) 2012, the patient was treated with open reduction internal fixation (orif) of the left leg.Eleven days post procedure, the event was considered recovering/resolving and was discharged to rehabilitation unit.Subsequently, the patient developed acute chest pain with nausea and diaphoresis at rehabilitation unit and was transferred to intensive acute care.The 100% thrombosis of the study stent was also treated with thrombectomy and placement of 3.0 x 16 mm promus element stent, with 0% residual stenosis.On (b)(6) 2013, the patient was discharged on aspirin and clopidogrel.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
ION?
Type of Device
CORONARY DRUG-ELUTING STENT
Manufacturer (Section D)
BOSTON SCIENTIFIC - MAPLE GROVE
one scimed place
maple grove MN 55311
Manufacturer Contact
ingrid matte
one scimed place
maple grove, MN 55311
7634941700
MDR Report Key3610529
MDR Text Key18768031
Report Number2134265-2014-00402
Device Sequence Number1
Product Code NIQ
Combination Product (y/n)N
Reporter Country CodeUS
PMA/PMN Number
P100023
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type Study,Health Professional,Company Representative
Reporter Occupation Physician
Type of Report Initial,Followup,Followup
Report Date 01/20/2014
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received02/06/2014
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Device Operator Health Professional
Device Expiration Date01/22/2013
Device Model NumberH7493902416300
Device Catalogue Number39024-1630
Device Lot Number14635980
Was Device Available for Evaluation? No
Is the Reporter a Health Professional? Yes
Date Manufacturer Received05/22/2014
Was Device Evaluated by Manufacturer? Device Not Returned to Manufacturer
Date Device Manufactured09/19/2011
Is the Device Single Use? Yes
Is This a Reprocessed and Reused Single-Use Device? No
Patient Sequence Number1
Patient Outcome(s) Hospitalization; Required Intervention;
Patient Age88 YR
-
-